NCT03382938View on ClinicalTrials.gov

Dexmedetomidine Wound Infiltration in Cesarean Section

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 23, 2019

Primary Completion Date

December 20, 2025

Study Completion Date

November 20, 2026

Conditions
Postoperative Pain
Interventions
DRUG

Dexmedetomidine

WOUND INFILTRATION IN CESAREAN SECTION

DRUG

Ropivacaine

WOUND INFILTRATION IN CESAREAN SECTION

DRUG

Dexmedetomidine - Ropivacaine

WOUND INFILTRATION IN CESAREAN SECTION

OTHER

0,9% saline

placebo WOUND INFILTRATION IN CESAREAN SECTION

Trial Locations (1)

13231

RECRUITING

Paraskevi K Matsota, Athens

All Listed Sponsors
lead

Attikon Hospital

OTHER